Nuveen »

Black Diamond Therapeutics shares owned by Nuveen

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Nuveen from 13F filings

Historical chart of Nuveen investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Nuveen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Nuveen

Quarter filed Position value Share count Share price at filing
2026-06-30 $120k 65k 1.85
2025-03-31 $4.6M 136k 34.26

More positions owned by Nuveen

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Micron Technology (MU)
Applied Materials (AMAT)
Lam Research Corp Com New (LRCX)
Advanced Micro Devices (AMD)

View all positions for Nuveen

Top funds holding Black Diamond Therapeutics

NEA Management Company
BlackRock
Acadian Asset Management
Vanguard Capital Management
Renaissance Technologies
Defilade Capital Management
Dimensional Fund Advisors
Geode Capital Management
Connor, Clark & Lunn Investment Management
AWM Investment Company
Marshall Wace
Bridgeway Capital Management
FMR
Balyasny Asset Management
Bank of America Corporation

View all funds holding Black Diamond Therapeutics